TECON(SZ:002100) Xin Lang Cai Jing·2025-11-03 02:07Core Viewpoint - TianKang Biological experienced a stock price increase of 2.03% on November 3, reaching 7.53 CNY per share, with a total market capitalization of 10.28 billion CNY [1] Company Overview - TianKang Biological Co., Ltd. is located in Urumqi, Xinjiang, and was established on December 28, 2000, with its stock listed on December 26, 2006 [1] - The company specializes in the production and sales of biological vaccines for livestock and poultry, feed, plant protein, breeding of breeding pigs, pig farming, slaughter processing, and meat product sales [1] - The revenue composition includes: 32.20% from pig farming, 27.51% from feed, 16.37% from protein and oil processing, 14.75% from corn, 5.44% from veterinary drugs, and 3.40% from other sources [1] Financial Performance - For the period from January to September 2025, TianKang Biological achieved an operating income of 13.61 billion CNY, representing a year-on-year growth of 4.00%, while the net profit attributable to shareholders decreased by 27.20% to 412 million CNY [2] - The company has distributed a total of 1.89 billion CNY in dividends since its A-share listing, with 598 million CNY distributed over the past three years [3] Shareholder Information - As of October 20, 2025, the number of shareholders decreased by 1.20% to 59,800, while the average number of circulating shares per person increased by 1.21% to 22,815 shares [2] - Notable institutional holdings include: Guotai Zhongzheng Livestock Breeding ETF as the fifth largest shareholder with 24.30 million shares, an increase of 8.75 million shares; Hong Kong Central Clearing Limited as the seventh largest shareholder with 15.03 million shares, a new entry; and Jiashi Agricultural Industry Stock A as the eighth largest shareholder with 13.91 million shares, an increase of 3.61 million shares [3]